Please complete the CAPTCHA to continue
A concise factual answer block for searchers comparing this professional profile.
Martin Van Eijk is listed as Researcher Life Sciences based in The Randstad, Netherlands, Netherlands. AeroLeads shows a matched LinkedIn profile for Martin Van Eijk.
Martin Van Eijk previously worked as Project Coordinator, Research scientist ZonMw/NCFS at Utrecht University and Project Coordinator, Research scientist STWproject(OTP) and STW Demonstrator program. at Universiteit Utrecht. Martin Van Eijk studied at Utrecht University.
Immunobiochemist, expert on the structure and function of several innate immune components (collectins and host defense peptides) and their protective roles in host defense against bacterial, fungal and viral infections. Trained as a biochemical research technician: over 10 years experience within life science research involving a wide range of biochemical, immunological, molecular, cellular, and microbiological techniques. Further developed scientific skills at Oxford University and Boston University Medical Center. PhD (2003) on molecular characterization of respiratory innate immune proteins and their interactions with immune cells and influenza A viruses. Experienced multidisciplinary life science researcher. Developed teaching, training and coaching skills by supervising and coaching bachelor, master, and PhD students. Supervised and coordinated several research projects aimed at the development of novel anti-infectives to treat respiratory microbial infections in humans. Lead inventor of several patent applications on antimicrobial proteins and peptides with distinct pathogen killing properties.
Listed skills include Biochemistry, Protein Chemistry, Research, In Vitro, and 10 others.
A career timeline built from the work history available for this profile.
Utrecht Area, Netherlands
Development of novel anti-infectives for treatment of respiratory infections in patients with Cystic Fibrosis.This project aims to develop a novel peptide-based antimicrobial drug that can be used to treat respiratory (persistant) infections in CF-patients more effectively as compared to currently applied conventional antibiotics. Based upon our knowledge.
Utrecht Area, Netherlands
Development of novel antivirals based on recombinant surfactant protein DInfluenza epidemics continue to occur annually causing excess morbidity and mortality in humans. The continuous threat of pandemic outbreaks requires novel means of protection since vaccination strategies (time-consuming) and currently available antiviral drugs (viral resistance) can.
Lelystad, The Netherlands
Pestiviruses, which include economically important animal pathogens such as bovine viral diarrhea virus and classical swine fever virus, possess three envelope glycoproteins, namely Erns, E1, and E2. Focus of this project was to identify the immunodominant and virus-specific epitopes on Erns and E2 by the use of 3D-structured 'CLIPS'-peptides. These.
Utrecht Area, Netherlands
EU consortium Research project "Antimicrobials through Immune Stimulation" (AMIS).Design, production, and characterization of novel recombinant innate immune-based (hybrid) proteins to develop innovative innate immune-based strategies. Investigate their potential as a more effective alternative means for currently available antibiotics/antivirals and aimed.
Department Of Biochemistry And Cell Biology
Research on porcine collectins to dissect their role in respiratory antiviral defense against influenza A viruses (IAVs) in this animal species, known for its mixing vessel potential as regards IAVs and the emergence of novel pandemic strains. Keywords: C-type lectins, influenza, innate immunity, pandemics, sialic acids, N-glycosylation, hemagglutinin.
Study interactions between porcine collectins and influenza A viruses in vitro.Pigs are (among the animal species studied so far) the only species that have adistinct glycosylation profile present on SP-D. Since these animals are consideredimportant for interspecies transmission of IAV, the anti-influenza activity of porcine SP-D wasextensively studied in.
Oxford, United Kingdom
Cloning, characterization and chromosomal localization of porcine pulmonary surfactant protein D (SP-D)cDNA cloning and sequence analysis of the full-length cDNA revealed that the predicted protein sequence contains unique features that are absent in the SP-D of other species previouslycharacterized. Amongst these features was the presence of an.
Utrecht Area, Netherlands
Pulmonary surfactant research, including studies on the structure and function of surfactant proteins, their interactions with surfactant lipids, and composition analysis of surfactant-based products and preparations derived from bronchoalveolar lavage. Developed a broad range of methods and skills on protein and lipid (bio)chemistry, immunology.
Quick answers generated from the profile data available on this page.
Martin Van Eijk is listed as Researcher Life Sciences.
Martin Van Eijk is based in The Randstad, Netherlands, Netherlands.
Martin Van Eijk has worked for Utrecht University, Universiteit Utrecht, Wageningen University & Research, Boston University School Of Medicine, and University Of Oxford.
You can use AeroLeads to view verified contact signals for Martin Van Eijk, including work email, phone, and LinkedIn data when available.
Martin Van Eijk studied at Utrecht University.
Martin Van Eijk is listed with skills including Biochemistry, Protein Chemistry, Research, In Vitro, Immunology, Life Sciences, Cell Culture, and Molecular Biology.
Search by job title, company, industry, location, and seniority. Export verified B2B contact data when you need it.
Start free trial Search contactsCheck these profiles if this is not the Martin Van Eijk you were looking for.
